2025
SJR Q2
JCR Q3 · 2,7
91 matched articles
SCIE
Journal detail
Clinical and Translational Oncology
- Publisher
- Springer Science and Business Media Deutschland GmbH
- Country
- Germany · Western Europe
- Type
- journal
- ISSN
-
1699048X16993055
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,833
- Quartile Q2
- H-Index 69
- Cites/doc 2,81
- Docs (3y) 813
- Cites (3y) 2.443
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,7
- 5Y JIF 2,9
- JCI 0,49
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Cancer Research Q3
- Medicine (miscellaneous) Q2
- Oncology Q2
Areas
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS categories
- Oncology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,833 | 2,7 | 2,9 | 0,49 | Q3 | 69 |
| 2024 | Q2 | Q3 | 0,903 | 2,5 | 2,7 | 0,57 | Q3 | 65 |
| 2023 | Q2 | Q2 | 0,837 | 2,8 | 2,9 | 0,6 | Q3 | 65 |
| 2022 | Q2 | Q3 | 0,831 | 3,4 | 3,1 | 0,62 | Q3 | 65 |
| 2021 | Q2 | Q3 | 0,764 | 3,3 | 3,1 | 0,64 | Q3 | 65 |
| 2020 | Q2 | Q3 | 0,902 | 3,4 | 3,1 | 0,64 | Q3 | 65 |
| 2019 | Q2 | Q3 | 0,833 | 2,7 | 2,5 | 0,65 | Q3 | 65 |
| 2018 | — | Q3 | — | 2,4 | 2,1 | 0,64 | Q3 | — |
| 2017 | Q2 | Q3 | 0,819 | 2,4 | 2,1 | 0,6 | Q3 | 65 |
| 2016 | Q2 | Q3 | 0,774 | 2,4 | 2,1 | — | — | 65 |
| 2015 | Q2 | Q3 | 0,865 | 2,1 | 1,7 | — | — | 65 |
| 2014 | Q2 | Q3 | 0,746 | 2,1 | 1,6 | — | — | 65 |
| 2013 | Q2 | Q4 | 0,589 | 1,6 | 1,4 | — | — | 65 |
| 2012 | Q2 | Q4 | 0,529 | 1,3 | 1,3 | — | — | 65 |
| 2011 | Q2 | Q4 | 0,54 | 1,3 | — | — | — | 65 |
| 2010 | Q2 | Q4 | 0,515 | 1,3 | — | — | — | 65 |
| 2009 | — | Q4 | — | 1,1 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | ONCOLOGY | SCIE | Q3 | Q3 | 185/333 |
| 2024 | ONCOLOGY | SCIE | Q3 | Q3 | 188/328 |
| 2023 | ONCOLOGY | SCIE | Q2 | Q3 | 157/322 |
| 2022 | ONCOLOGY | SCIE | Q3 | Q3 | 125/241 |
| 2021 | ONCOLOGY | SCIE | Q3 | Q3 | 165/245 |
| 2020 | ONCOLOGY | SCIE | Q3 | Q3 | 160/242 |
| 2019 | ONCOLOGY | SCIE | Q3 | Q3 | 157/244 |
| 2018 | ONCOLOGY | SCIE | Q3 | Q3 | 154/230 |
| 2017 | ONCOLOGY | SCIE | Q3 | Q3 | 156/223 |
| 2016 | ONCOLOGY | SCIE | Q3 | — | 142/217 |
| 2015 | ONCOLOGY | SCIE | Q3 | — | 153/213 |
| 2014 | ONCOLOGY | SCIE | Q3 | — | 148/211 |
| 2013 | ONCOLOGY | SCIE | Q4 | — | 159/203 |
| 2012 | ONCOLOGY | SCIE | Q4 | — | 163/197 |
| 2011 | ONCOLOGY | SCIE | Q4 | — | 153/196 |
| 2010 | ONCOLOGY | SCIE | Q4 | — | 147/185 |
| 2009 | ONCOLOGY | SCIE | Q4 | — | 138/166 |